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Objective. We describe an outbreak of VIM-carbapenemase 
Klebsiella oxytoca (VIM-Kox) in a NICU 
Materials and methods. Prospective Epidemiological Surveillance:
a) Systematically (weekly screening cultures) or on admission, if 
the patient had a history of previous colonization by VIM-Kox.
b) Clinical cultures, done if infection was suspected.
c) Other possible microorganism sources were investigated: their 
mothers (rectal microbiota), milk packages and preparation appa-
rata in the lactodietary section, echocardiagram transductors, 
cribs, the sinks (faucets and drains), washing bowls, etc. 
Molecular typing was performed using the DiversiLab (bio-
Mérieux) system on all VIM-Kox isolated from environment or 
patients (one by neonate).
Results. We identified 20 VIM-Kox cases, the most only pre-
sented colonization, but 4 showed infection. Three of the ten sinks 
(drains) in our NICU, were positive for VIM-Kox. Another four 
drains harbored P.aeruginosa, S. maltophilia and/or Enterobac-
ter sp. Nevertheless the VIM-Kox bacteria in the sinks (drains) 
were not the same as those in the patients, who showed three dif-
ferent strains. 
Conclusions. A VIM-Kox colonization or infection outbreak in a 
NICU is described. Rather than environment, not even drains, the 
source of the outbreak was other patients. The outbreak was rela-
tively brief, as a result of the rapidness with which appropriate 
measures were taken and followed.
Original article
VIM-Klebsiella oxytoca outbreak in a Neonatal Intensive 
Care Unit. This time it wasn’t the drain
R. HERRUZO1, G. RUIZ2, S. GALLEGO3, J. DIEZ3, A. SARRIA2, F. OMEÑACA4
1 Department of Preventive Medicine and Public Health and Microbiology, School of Medicine, Autonomous University of Madrid, 
Spain;2 Microbiology Service, Universitary Hospital “La Paz”, Madrid, Spain; 3 Preventive Medicine Service, Universitary Hospital 
“La Paz”, Madrid, Spain; 4 Neonatology Service, Children Hospital.Universitary Hospital “La Paz”, Madrid, Spain
Keywords
VIM-Klebsiella oxytoca • NICU • Sink (drain)
Summary
J PREV MED HYG 2017; 58: E302-E307
Introduction
The frequency of carbapenemase-producing microor-
ganism isolation in tertiary hospitals has been rising 
since 2007  [1], particularly Enterobacteriaceae [2-6]. 
Molecular biology techniques have detected antibiotic 
resistance genes like carbapenemase Ambler types A, B 
and D  [7]. The Class B or metallo-betalactamases can 
be divided into three different types: the IMP, VIM and 
NDM.
When a new patient is colonized or infected by micro-
organisms with carbepenemases, it is necessary to deter-
mine whether this is due to microorganisms from other 
patients or from reservoirs that are difficult to clean dur-
ing the inter-patient room cleaning/disinfection [8-12].
These reservoirs have sometimes been seen with hydro-
philic bacteria like P. aeruginosa, B. cepaciae, or Kleb-
siella oxytoca with carbepenemase associated with sink 
contamination [13-18]. The drains of these sinks can 
harbor biofilms, which, in addition to hampering dis-
infection, can facilitate microorganism survival, gene 
interchange among microorganisms, and later, their 
dispersion as aerosols that can contaminate patients or 
healthcare workers when the sink is used for personal 
hygiene [18].
The microorganisms typing is useful to diagnose trans-
mission and also allows us to detect if there is an out-
break or only a cluster of unrelated cases and establish 
monitoring systems to survey compliance with the pre-
vention measures.
Carbepenemase-producing K. oxytoca were previ-
ously isolated in patients from some Spanish hospi-
tals  [1, 19-21]. Although this microorganisms can har-
bour plasmids with VIM-metallo-betalactamase (VIM-
Kox), we had not found any reference to a previous 
outbreak among neonates. In this paper we report an 
outbreak by VIM-Kox in a NICU at a tertiary children’s 
hospital, and describe the preventive measures taken to 
control further spread of this microorganism. 
Materials and methods
La Paz Children’s Hospital is a tertiary hospital with one 
NICU. Since 1985 monitoring and control of hospital 
infection is performed by one medical epidemiologist 
(part-time) and one nurse epidemiologist (dedicated full 
time). 
Different multidrugs resistant microorganisms surveil-
lance strategies are employed, including surveillance of 
clinical microbiology laboratory results, obtained during 
clinical care, and routine screenings to detect asympto-
matic colonization.
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Epidemiological surveillance for infection or coloniza-
tion by these microorganisms is performed in two ways: 
1. systematically, with an active surveillance methodol-
ogy using weekly screening cultures taken from all 
children admitted to the NICU;
2. at admission, if the patient has a previous multidrugs 
resistant microorganisms  colonization history. 
A “VIM-Kox-case” is determined by the identification 
of K. oxytoca with VIM-carbepenemase in any biologi-
cal sample taken from the patient (catheter tip, bron-
choalveolar exudate, blood, conjunctiva, throat, rectal, 
etc.), regardless of the presence of symptoms. On some 
occasions, a patient was colonized by different VIM-En-
terobacteriaceae genera.
Bacteria frequency was measured as a “cummulative 
incidence” of cases in a given time period (new cases 
divided by the number of children admitted during this 
period in our NICU, multiplied by 100).
A) Microbiological method
Surveillance studies in patients:
A.1) Clinical Samples
In neonates with any symptom of infection, urine, blood, 
broncho-alveolar lavages and other samples based on the 
most likely focus of infection were taken.
Antibiotic susceptibility was determined in clinical 
samples using the Wider (Fco. Soria Melguizo, Madrid, 
Spain) or Vitek (bioMérieux, Marcy l’Étoile, France) 
systems. Isolates were categorized as susceptible or re-
sistant to any of the antibiotics tested following CLSI 
guidelines. Tigecycline Minimun Inhibitory Concentra-
tion (MIC) were evaluated according to the interpretative 
criteria of the FDA. Extended-spectrum β-Lactamase 
production was confirmed by E-test extended-spectrum 
β-Lactamase  strips (bioMérieux) and carbapenem MIC 
were confirmed by E-test (BioMérieux). To rule out car-
bapenemase production, a modified Hodge test was per-
formed on all Enterobacteriaceae isolates retrieved from 
clinical cultures having an MIC ≥ 1 mg/L to imipenem 
or meropenem and an MIC  ≥  0.5 mg/L to ertapenem. 
The inhibition tests with boronic acid and EDTA were 
used to screen for the production of class A and class B 
carbapenemases.
A.2) Surveillance Samples
Weekly samples were obtained from the neonates’ phar-
ynx, nose, feces, catheter entry points and connections, 
and the incubator water. 
These samples were cultured in MacConkey agar sup-
plemented with 4mg/L of cefotaxime (Tec-Laim, Ma-
drid, Spain). Disc diffusion and a modified Hodge test 
were performed on all Enterobacteriaceae isolates to 
identify extended-spectrum β-Lactamase, plasmid-me-
diated AmpC and carbapenemase production. 
We mapped the VIM-colonized (or infected) patients 
within the NICU. Carbapenemase genes were confirmed 
by PCR (Progenie Molecular, Valencia, Spain). Molecu-
lar typing was performed using the DiversiLab (bioMé-
rieux) system on all KoVIM isolated from environment 
or patients (one by neonate).
B) Control measures
The bundles recommended for controlling VIM-Entero-
bacteriaceae were adapted from those described in CDC 
2012 [21-24] (Tab. I).
Our Epidemiologist-Nurse evaluated implementation of 
these measures daily, reporting any compliance failures 
to the healthcare workers. The Medical-Epidemiologist 
reinforced these daily recommendations with the NICU 
supervisors for doctors and nurses.
C) Statistical method
We studied the data for frequencies of children infected/
colonized per week, (incident cases), plotting an epi-
demic curve. 
Tab. I. Measures used in NICU by to control the outbreak of VIM-K. 
pneumoniae.
a) Early detection and implementation of contact precautions, 
emphasizing hand hygiene with alcohol solutions. The efficacy 
of the alcohol solution actually used in neonates was tested 
with VIM-microorganism recently isolated in our NICU.
b) Cohorting the VIM cases, grouping them in one specific 
area of the NICU. 
c) Cohorting the healthcare workers, especially nurses. In 
the first month, physicians were also dedicated to the VIM-
cases, but after that time, they also cared for other non-VIM 
patients.
d) Restriction of β -lactam-antibiotic use in neonates 
and limitation to sensitive antibiotics (according to the 
antibiogram) if the neonate carried VIM- microorganisms. 
e) Flagging the patient’s clinical history with a green-colored 
page stating the contact precautions, used when the child 
was taken out of the unit for clinical tests, etc. This same 
signalling page was used if the child was readmitted to our 
hospital. 
f) Daily body washing used a 0.1%-0.5% aqueous 
chlorhexidine solution (0.1% in preterm < 4 weeks of life or 
a term < 2 weeks; in preterm > 4 weeks of life or a term > 2 
weeks, chlorhexidine is used at 0.5%). 
g) Restriction of number of healthcare workers from other 
specialties who came to visit neonates.
h) Information sessions for parents and refresher courses 
for NICU doctors, nurses, assistants, and specialists, held to 
explain the epidemiological evolution of VIM bacteria and the 
steps to be taken during each phase.
i) The possible environmental origins of this VIM bacteria 
outbreak were explored early on, and included sinks, NICU 
surfaces, disinfectants, eyewashes, echograph-transductors 
etc., that could be related with the outbreak. Milk from 
the Dietetary Service, instruments and milk recipients were 
sampled, and also the water faucets in the NICU were studied 
fortnightly (between February and March). The samples were 
taked with swabs immediately before bein immersed in Tood-
Hewitt broth.
j) Other measures taken to interrupt the epidemiological 
evolution of the outbreak were to test the efficacy of 
disinfectant used on surfaces (double application of diluted 
quaternary ammonium and isopropyl-alcohol to the same 
surface) with VIM –microorganisms from our NICU, on a glass-
germ-carrier, as previously described [21, 24].
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Results
The VIM-Kox NICU outbreak began in the first week of 
February 2014. The weekly microbiota control sample 
(performed weekly on Thursdays) identified 8 VIM-Kox 
cases (4 also had VIM-Serratia). There were another 
3 patients in whom other VIM -Enterobacteriaceae were 
identified. The results for all the patients with multidrugs 
resistant microorganisms were received on the Monday 
of the second week of February, and all neonates with 
these microorganisms were placed under contact pre-
cautions, but it was not possible to establish an isolated 
cohort. Thursday that week, samples were again taken, 
and another six neonates had become VIM-Kox positive. 
Consequently, the first fortnight in February had a VIM-
Kox cummulative incidence of 21% (Fig. 1), 40 times 
higher than during the two previous years. 
The preventive measures mentioned in “Materials and 
methods” were taken.The effectivity of the hand anti-
septic against the bacteria recently isolated from patients 
was studied and found to be very effective within 15 sec-
onds. Moreover, the double application of diluted qua-
ternary ammonium and isopropyl-alcohol to the same 
surface, destroyed, in vitro, all VIM-microorganisms 
studied. Consequently, it was not necessary to change 
these methods of antisepsis and disinfection.
Last, a cohort with VIM-neonates was established. 
However, it was not possible to include all the affect-
ed babies, since, due to their underlying disease not all 
could be moved into the cohort isolation area. 
In the second fortnight of February, VIM-Kox cummulative 
incidence was slightly lower (16%). At this point other pos-
sible microorganism sources were investigated: their moth-
ers (rectal microbiota), sink drains, milk packages and prepa-
ration apparata in the lactodietary section, echocardiagram 
transductors, cribs, the sinks (faucets and drains), washing 
bowls, etc. Everything, except for three of the ten sinks, 
were negative for VIM-Kox.  Another four drains harbored 
P.aeruginosa, S. maltophilia and/or Enterobacter sp. (Fig. 2). 
Next, the susceptibility of these VIM-Enterobacteriace-
ae to different non-chlorinated desinfectants was deter-
mined. Chlorinated products were not used because they 
may emit gases that could irritate the neonate respiratory 
tract. All VIM-bacteria in this outbreak were susceptible 
to chlorhexidine, oxygen peroxide or alcohol, and mod-
erately resistant to diluted quaternary ammonium. Once 
susceptibility was determined, the drains were disinfect-
ed by pouring 1 liter of 5% clorhexidine down the drain. 
This was effective in two of the three VIM-Kox-affected 
sinks. The third sink required, as we have done in other 
bacterial outbreaks, an application of steam (vapor) and 
after a chemical disinfectant (in this case a mixture of 
3% hydrogen peroxide and lactic acid, which had given 
a good in vitro result). This treatment was applied in 
the ten affected sinks and the subsequent controls were 
negative in all cases for VIM-Kox as well as other mul-
tidrugs resistant microorganisms. Additionally, the num-
ber of HCW from other Services who were attending the 
neonates was restricted and in the third fortnight, the cu-
mulative incidence had dropped to 12% and then 0% in 
the fourth fortnight after the outbreak began.  There was 
only one new case in April with none in May or June, at 
which time the outbreak was considered over (Fig. 1). 
As seen in Figure 2, the locations of incubators with 
cases were widely scattered throughout the unit, and 
were not particularly related with the sinks in which 
VIM-Kox had been isolated. Moreover, the Microbiol-
ogy Laboratory confirmed via genetic analyses that the 
sink´s VIM-Kox were different to those of the cases and, 
among the 20 cases, there were three different strains. 
The first strain, isolated in the first fortnight of February 
(cases 1 to 8 ) remained until the first fortnight in March 
(case 15) affecting patients in the three “areas” (303, 304 
and 308); The second strain spread during the second 
Fig. 1. Cummulative incidence (%) for VIM-K. Oxytoca vs other VIM Enterobacteriaceae in NICU.
arrow =  more extreme contact precautions
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fortnight in February (cases 9 to 14) and first fortnight 
in March (cases 17 to 19), also with cases in the three 
NICU areas, and, in this fortnight in March, a third strain 
was identified, but only in 303 area (case 16). 
During the outbreak, three children were admitted to 
the hospital and found to be already VIM-Kox positive, 
colonized in another hospital, and their data are not con-
sidered in the analysis of the outbreak. 
The third of these children was admitted in the first fort-
night in April, and the last incident case to be detected in 
this outbreak was detected in the second fortnight of the 
month (case 20); he was probably, although we do not 
have the genetic study, infected by the outside case since: 
1) it had been nearly a month since the last case;
2) they were near each other in the same room;
3) in the first two weekly controls in which they were 
both sampled, case 20 was still negative, only becoming 
positive at the end of the second fortnight in April. 
In all, the NICU had 20 cases of VIM-Kox (4 of them had 
VIM-Kox and VIM-Seratia and 6 with other VIM-Entero-
bacteriaceae). Of the VIM-Kox cases most were only colo-
nizations but 4 also had infection (3 pneumonias and one 
conjunctivitis, Table II). These bacteria were susceptible 
to various antibiotics: Ertapenem, Meropenem, Amikacin, 
Colistin, Tigeciclin and quinolones. In each patient, the me-
dian of surveillance studies from admission to event was 3. 
VIM-Kox was also isolated in 6 other infants admit-
ted outside the NICU, and there were 3 patients (com-
ing from other hospitals) that entered the NICU already 
colonized with VIM-Kox.
Discussion
VIM-Kox has been few isolated in our neonates by 
epidemiological surveillance during the two previous 
years  [21], with an incidence between 0.1% and 0.3%. 
Other hospitals, or even the community [25], may be 
the reservoirs of these microorganisms. Several stud-
ies [13-17] have related K. oxytoca outbreaks with very 
damp environmental reservoirs, like sink drains in pa-
tients’ areas or the sinks in ICU’s. On this occasion, these 
microorganisms were found in 30% of the sink (drains) 
in our NICU, but the genetic analysis showed that the 
sink VIM-Kox´s were different from those in the neo-
nates.  Nevertheless the sinks were disinfected with heat 
plus chemicals and the VIM-Kox microorganisms were 
eliminated from that reservoir (at least temporarily).
Separation into two cohorts (with and without VIM bac-
teria) as well as applying contact precautions have given 
good results in prior outbreaks (with an OR > 5 for infect-
ed and OR > 30 for colonized patients [24]), and were en-
acted as soon as possible, producing a large reduction in 
incidence (Fig. 1) as soon as the measures were in place.
However at times it was impossible to transfer the neo-
nates in whom VIM- bacteria had been detected in the 
weekly sampling to the isolation area on the day colo-
nization was microbiologically confirmed, and this may 
Fig. 2. Summary of VIM-K. oxytoca cases (Feb.-May) in NICU: location of cases and faucets-sinks.
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have placed the neonates in their immediate surroundings 
at risk, although the neonate with possible multidrug re-
sistant microorganisms had been placed under contact re-
strictions from the time of their first suspected diagnosis.
From these facts, it follows that the main cause of VIM-
Kox´s transmission was that the lack of adherence to con-
tact precautions measures by some health care workers.
In any hospital outbreak it is necessary to evaluate the ef-
fectiveness of the existing antiseptic and disinfection pro-
tocols against the outbreak organisms. The already recom-
mended alcohol solution for hands, and surface desinfect-
ants, were effective against the patients’ VIM-Kox strains. 
In addition to all of the above, these measures, which sup-
pose an organizational challenge within the NICU, must be 
accompanied by refresher hygiene training for all health-
care workers, as well as regular updates on the evolution 
of the outbreak so as to increase or maintain the existing 
measures and evaluate if there have been any failures so 
that these failures can be corrected as soon as possible. 
Study limitations
1) Antibiotic effect has not been evaluated directly in neo-
nate fecal microbiota, since microorganism diagnosis was 
qualitative, not quantative, and only detected the presence 
or absence of a given bacteria, but not its quantity in a giv-
en sample weight. Quantification would have made it pos-
sible to use this variable as an indicator of recent contami-
nation or of susceptibility to VIM-bacteria multiplication 
(in competition with the other intestinal microbiota). 
2) Microbiota studies more frequently than once a week 
have not been possible, even at the peak of the outbreak 
(differently from previous outbreaks), possibly delaying 
the establishment of precautionary measures like contact 
control and cohort grouping for children with recently 
acquired VIM-bacteria by a few days, and slightly in-
creasing the possibility of multidrugs resistant microor-
ganisms transmission to other neonates. 
3) Compliance with control measures (hand samples, 
observation at established times, etc.) has not been ob-
jectively evaluated, and evaluation has only been qualita-
tive by observation and speaking with healthcare work-
ers who did not complete all the steps for controlling 
these multidrug resistant microorganisms. What is more, 
epidemiological surveillance was only done during the 
morning shift, occasionally in the afternoon, and never 
in the evening shift. 
Conclusions
• A VIM-Kox colonization/infection outbreak in a 
NICU is described. 
• The outbreak was relatively brief, as a result of the 
rapidness with which appropriate measures were 
taken and followed (at least during the time in which 
compliance was directly observed).
• The already recommended alcohol solution for hands 
and surface desinfectants were effective against the 
patients’ VIM-Kox strains.
• The source of the VIM-Kox microorganisms was 
other patients, but not the mothers or environment 
(milk, milk preparation material, NICU apparata, 
etc.), or even the drains in the NICU (which, how-
ever, were reservoirs for other VIM-Kox strains). 
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